Xian Lu

2.8k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Xian Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Xian Lu has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Xian Lu's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (7 papers). Xian Lu is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (7 papers). Xian Lu collaborates with scholars based in United States, Canada and China. Xian Lu's co-authors include D. Ross Camidge, Robert C. Doebele, Anna E. Barón, Dara L. Aisner, Andrew Weickhardt, Paul A. Bunn, Joseph Burke, Gregory N. Gan, Brian D. Kavanagh and Laurie E. Gaspar and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xian Lu

38 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

2012 508 citations Andrew Weickhardt, Xian Lu et al. Journal of Thoracic Oncology profile →

Peers

Countries citing papers authored by Xian Lu

Since Specialization

Citations

This map shows the geographic impact of Xian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian Lu more than expected).

Fields of papers citing papers by Xian Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian Lu. The network helps show where Xian Lu may publish in the future.

Co-authorship network of co-authors of Xian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xian Lu. A scholar is included among the top collaborators of Xian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xian Lu. Xian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	In vitro slow-growth conservation, acclimatization, and genetic stability of virus-free apple plants	SHILAP Revista de lepidopterología	Xian Lu, Ruihan Liu et al.	2
2	A Neural Circuit From Paraventricular Nucleus of the Thalamus to the Nucleus Accumbens Mediates Inflammatory Pain in Mice	Brain and Behavior	Xi Liu, Xi Zhang et al.	1
3	Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial	International Journal of Radiation OncologyBiologyPhysics	Alexander D. Sherry, Cara Haymaker et al.	1
4	Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers	BMC Cancer	Xian Lu, Jonn Wu et al.	4
5	Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients	Oral Diseases	Xian Lu, Eitan Prisman et al.	8
6	Plasma-Derived Inflammatory Proteins Predict Oral Squamous Cell Carcinoma	Frontiers in Oncology	Xian Lu, Yuqi Zhu et al.	17
7	Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung	Journal of Thoracic Oncology	Sinéad Noonan, Tejas Patil et al.	19
8	Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR	Scientific Reports	Curtis Hughesman, Xian Lu et al.	10
9	Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis	Journal of Thoracic Oncology	Sinéad Noonan, Lynne D. Berry et al.	126
10	A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens	PLoS ONE	Curtis Hughesman, Xian Lu et al.	35
11	A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry	Journal of Thoracic Oncology	Caroline E. McCoach, Eamon M. Berge et al.	43
12	Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF-β1–Induced Epithelial–Mesenchymal Transition	Cancer Research	Patrick Nasarre, Robert M. Gemmill et al.	55
13	Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression	Journal of Thoracic Oncology	Sunny Guin, Yuanbin Ru et al.	39
14	Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel	Molecular Cancer Therapeutics	Diana M. Cittelly, Irina Dimitrova et al.	104
15	A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer	Journal of Thoracic Oncology	Andrew Weickhardt, Robert C. Doebele et al.	46
16	Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer	Cancer	Robert C. Doebele, Xian Lu et al.	223
17	Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma	Journal of Thoracic Oncology	Daniel C. Christoph, Bernadette Reyna Asuncion et al.	34
18	Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed	Journal of Thoracic Oncology	D. Ross Camidge, Scott A. Kono et al.	195
19	Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas	Oral Oncology	Xiaotian Wang, Fang Zhang et al.	71
20	Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats	Basic Research in Cardiology	Lei Yao, Xian Lu et al.	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact